openPR Logo
Press release

Clostridium Difficile Diagnostics and Treatment Market – Insights

05-05-2018 01:03 PM CET | Health & Medicine

Press release from: Medical Devices

Clostridium Difficile Diagnostics and Treatment Market –

Clostridium difficile is a disease caused by bacteria. Symptoms of the disease includes diarrhea, nausea, colon inflammation, and others. Clostridium difficile infection affects older adults, and according to Centers for Disease Control and Prevention (CDC), 2015, clostridium difficile infection is the most common healthcare-associated infection. Furthermore, frequent use of antibiotic medication is also responsible for clostridium difficile infection, as antibiotics kill normal flora (good bacteria) and allow for multiplication of C. difficile bacteria. Common symptoms of clostridium difficile infection include watery diarrhea, dehydration, fever, nausea, loss of appetite, and weight loss. Life threatening symptoms of the disease includes abdominal distension, severe abdominal pain, and profuse diarrhea. Clostridium difficile infection management includes diagnosis of the infection using various tests and medication therapies using antibiotics such as Vancomycin and Fidaxomicin.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/1499

Rising prevalence of clostridium difficile infection is expected to boost growth of the market over the forecast period

Incidence of clostridium difficile infection has been witnessing an increase in the recent past, due to clostridium difficile infection recurrence and antibiotic resistance. According to Centers for Disease Control and Prevention (CDC), 2015, around half a million people in the U.S. suffer from clostridium difficile infection in a year. Moreover, according to National Center for Biotechnology Information (NCBI), an estimated 37,900 patients were suffering from clostridium difficile infection in Canada in 2012. A review and meta-analysis of studies published in National Center for Biotechnology Information (NCBI), 2016, conducted in China between 2010 and 2016 showed significant incidence of clostridium difficile infection in China. Furthermore, according to Canadian Antimicrobial Resistance Surveillance System 2017 Report, clostridium difficile infection may be a consequence of commonly prescribed antibiotics for unrelated infections. According to Organization for Economic Co-operation and Development (OECD), 2015, antibiotic resistant bacteria are highly prevalent in G7 countries. This high presence of antibiotic resistant bacteria may lead to increasing incidence of the infection, which in turn is expected to aid in growth of the global clostridium difficile diagnostics and treatment market.

The global clostridium difficile diagnostics and treatment market was valued at US$ 1,272.2 million in 2016 and is expected to witness a robust CAGR of 8.2% over the forecast period (2017–2025).

Robust pipeline of various therapies is expected to boost growth of the clostridium difficile treatment market over the forecast period

Standard antibiotic drugs such as metronidazole, Vancomycin, and Fidaxomicin have been used for the treatment of clostridium difficile infection (CDI) since the recent past. Currently, there is no alternative therapies apart from antibiotics available for the treatment of clostridium difficile infection and only option available is surgery (in severe cases), fecal microbiota transplant, and probiotics in case of recurrent clostridium difficile infection. However, Manufacturers such as Rebiotix, Inc., Synthetic Biologics, Inc., Da Volterra, Crestovo LLC, and Immuron Ltd. have various microbiome therapeutics (new class of drugs) in pipeline for clostridium difficile infection indication. Rebiotix, Inc. has RBX7455 capsule in Phase 1 clinical trials, Synthetic Biologics Inc. has SYN-004 (ribaxamase) in Phase 2 clinical trials, and Da Volterra has DAV132 in clinical trials for antibiotic induced clostridium difficile infection. If these drugs show success in clinical trials, it could provide an alternative therapy for conventional antibiotics for treatment of the disease. Furthermore, probiotics are also gaining traction as they allow growth of natural flora through restoring natural balance of bacteria in the gut. Manufacturers such as Pfizer, Inc. and Valneva are working on developing novel vaccines for the treatment of CDI. For instance, Pfizer, Inc. has recombinant TcdA and TcdB PF-06425090 vaccine in phase 2 trial and Valneva has VLA84 in phase 1 trial.

Ask for customization: https://www.coherentmarketinsights.com/insight/request-customization/1499

However, low awareness about clostridium difficile infection symptoms and associated effects is expected to restrain the growth of the clostridium difficile diagnostics and treatment market over the forecast period.

Some major players operating in the clostridium difficile diagnostics and treatment market include Roche AG, Thermo Fisher Scientific Inc., Merck & Co., Pfizer, Inc., Actelion Pharmaceuticals, Alere, Inc., Trinity Biotech, Summit Therapeutics, Baxter International Inc., Sanofi S.A., Novartis AG, and AstraZeneca Plc.

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Visit our news Website: http://www.coherentchronicle.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Clostridium Difficile Diagnostics and Treatment Market – Insights here

News-ID: 1040463 • Views:

More Releases from Medical Devices

Medical Aesthetics Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026
Medical Aesthetics Market - Global Industry Insights, Trends, Outlook, and Oppor …
Medical aesthetics is an area of medicine, dealing with aesthetics, well-being, external appearance, visible skin changes, and image of the patient. Medical aesthetics involve high-technology skin care procedures that represents the fusion of beauty and healthcare services. Procedures for these involves use of advanced technologies to enhance aesthetics of the person. Demand for anti-aging products and procedures is increasing significantly, owing to increasing focus of patients to look young and
Ophthalmic Ultrasound Imaging Systems Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026
Ophthalmic Ultrasound Imaging Systems Market - Global Industry Insights, Trends, …
Ophthalmic ultrasound imaging system is non-invasive visualization technique, which is more convenient and relatively inexpensive as compared to other techniques such as optical coherence tomography (OCT), magnetic resonance imaging (MRI), and scanning Scheimpflug. Ophthalmic ultrasound imaging systems allow imaging of anatomy and pathology involving the anterior and posterior segment of the eye. This system provides diagnostic information in conditions such as glaucoma, trauma, cysts, and neoplasms. It also allows measurement
Eye Anatomical Model Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025
Eye Anatomical Model Market - Global Industry Insights, Trends, Outlook, and Opp …
Eye anatomical model refers to the type of reference models that are used to study the internal and external structures of the eye. These models are majorly used by educational institutes and optometry departments by professors to explain the internal and external anatomy of the eye in detail. These are also found to be used by professional healthcare providers such as ophthalmologists as well as opticians to educate their patients
Cast Removal Device Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018- 2025
Cast Removal Device Market - Global Industry Insights, Trends, Outlook, and Oppo …
Cast removal devices are designed to cut cast material such as fiberglass, plastic or plaster and bandage that are used for rehabilitation of the fractured bones or ruptured tendons. It is mainly used by orthopedic surgeons in hospitals and clinics to cure musculoskeletal injuries caused due to road accidents and during sports practices. According to the U.S. Department of Health & Human Services report on January 2018, road traffic injuries

All 5 Releases


More Releases for Clostridium

Clostridium Difficile Diagnostics and Treatment Market – Insights
Clostridium difficile is a disease caused by bacteria. Symptoms of the disease includes diarrhea, nausea, colon inflammation, and others. Clostridium difficile infection affects older adults, and according to Centers for Disease Control and Prevention (CDC), 2015, clostridium difficile infection is the most common healthcare-associated infection. Furthermore, frequent use of antibiotic medication is also responsible for clostridium difficile infection, as antibiotics kill normal flora (good bacteria) and allow for multiplication of
The Global Clostridium Difficile Infection Treatment Market Driver
Clostridium difficile, which produces gram-positive bacterium, is an anaerobic toxin that gets transmitted through fecal-oral route. Clostridium difficile infection occurs during antibiotic treatment or can be caused due to healthcare associated infection with clinical manifestation ranging from asymptomatic infection to watery diarrhea or serious intestinal condition such as colitis and colonic perforation. This infection can be diagnosed by enzyme immunoassays for toxins or Clostridium difficile glutamate dehydrogenase (GDH) and nucleic
Clostridium difficile Infections (Clostridium difficile Associated Disease)Marke …
To Understand the pharmaceutical Industry Status worldwide, Market Research Hub (MRH) has included the latest Forecast report titled “Clostridium difficile Infections (Clostridium difficile Associated Disease)-Pipeline Review, H2 2017” to its vast database. This study offers data about the prime regions operating in the pharmaceutical sector, along with their production, consumption, revenue and market share details. Further, the intelligent report also anticipates that the market would grow at a constructive CAGR
Clostridium difficile Infections (Clostridium difficile Associated Disease)Marke …
To Understand the pharmaceutical Industry Status worldwide, Market Research Hub (MRH) has included the latest Forecast report titled “Clostridium difficile Infections (Clostridium difficile Associated Disease)-Pipeline Review, H2 2017” to its vast database. This study offers data about the prime regions operating in the pharmaceutical sector, along with their production, consumption, revenue and market share details. Further, the intelligent report also anticipates that the market would grow at a constructive CAGR
Clostridium Vaccine Market : Share, Analysis To 2024
The global clostridium vaccine (animal health) market features a largely consolidated competitive landscape, with the top five companies collectively accounting for a share of over 63% of the overall market in 2015, observes a recent report by Transparency Market Research (TMR). These top vendors, namely Zoetis, Inc., Merck & Co., Sanofi-Aventis, Boehringer Ingelheim, and Eli Lilly and Company hold commanding positions owing to their wide geographic presence and a strong
Clostridium Vaccine Market to Grow Exponentially
Global Clostridium Vaccines Market: Snapshot Clostridium vaccines are chiefly utilized for a variety of bovine and ovine clostridial diseases such as blackleg, pulpy kidney (enterotoxaemia), black disease, and tetanus. The demand for clostridium vaccine is rising globally owing to the increasing incidence rate of clostridium family diseases and increased awareness regarding zoonotic diseases. Rising concerns about the mortality of livestock animal and the socioeconomic impact of it on agrarian economies are